Author

Dylan Sun

Observed names: D. Sun, Sun, D., Sun, Dylan

Institution: Regeneron (United States)

Observed institutions: Regeneron (United States), University of Michigan, Pingry School

OpenAlex ID: A5108137703

Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

2020 · Sonia Shah, Albert Henry, et al. · Nature Communications · 838

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

2022 · Aleksejs Sazonovs, Christine R. Stevens, et al. · Nature Genetics · 195

Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

2019 · Shah, Sonia, Henry, Albert, et al. · Apollo (University of Cambridge) · 39

Circulating Tumor DNA Analysis Associates with Progression-Free Survival (PFS) with Odronextamab Monotherapy in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Identification of Minimal Residual Disease Status and High-Risk Subgroups from the Phase 2 ELM-2 Study

2023 · Jon E. Arnason, Jurriaan Brouwer-Visser, et al. · Blood · 3

A phase 1 study of REGN6569, a GITR mAb, in combination with cemiplimab in patients (pts) with advanced solid tumor malignancies: Initial dose-escalation results.

2024 · Nehal J. Lakhani, Omid Hamid, et al. · Journal of Clinical Oncology · 2

An Undergraduate Research Experience Studying Ras and Ras Mutants

2015 · Nancy Griffeth, Naralys Batista, et al. · IEEE Transactions on Education · 2

Dairy intake and body composition and cardiometabolic traits among adults: Mendelian randomization analysis of 182041 individuals from 18 studies

2024 · Bartz, T.M., Wojczynski, M.K., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 1

76P Impact of genomic alterations on clinical outcomes with first-line cemiplimab + chemotherapy for advanced NSCLC: An analysis from EMPOWER-Lung 3

2026 · V. Anagnostou, D.R. Gandara, et al. · ESMO Open

424 | LONGITUDINAL TARGETED ctDNA ANALYSIS TO ASSESS CD20 and BAFF MUTATIONS IN PATIENTS WITH RELAPSED/REFRACTORY FL OR DLBCL PROGRESSING ON ODRONEXTAMAB IN THE ELM‐2 STUDY

2025 · D. Tucker, J. E. Arnason, et al. · Hematological Oncology

Physical models of enzymes engineered for biofuel cells: 2010 Pingry School S.M.A.R.T. Team Project

2010 · Tommie Shintaro Hata, Scott Banta, et al. · The FASEB Journal

Works count: 10

Citation count: 1,080

H-index: 3

I10-index: 3